Mortality-lowering effect of systemic corticosteroid therapy in severe tetanus

Basit Öğe Kaydı
dc.authorid0000-0002-8335-1927en_US
dc.contributor.authorPaydaş, Semra
dc.contributor.authorAkoğlu, T. F.
dc.contributor.authorAkkız, Hikmet
dc.contributor.authorÖzer, F. L.
dc.contributor.authorBurgut, Hüseyin Refik
dc.date.accessioned2024-07-12T21:03:04Z
dc.date.available2024-07-12T21:03:04Z
dc.date.issued1988en_US
dc.departmentFakülteler, Tıp Fakültesien_US
dc.description.abstractIn a double-blind therapeutic trial, 32 patients suffering from severe tetanus were given prednisolone and 31 a placebo in addition to standard treatment. Mortality was lower in the prednisolone-treated group (31%) than in the placebo-treated group (55%). The women had more severe symptoms and a higher mortality than the men. The results suggest that the addition of a corticosteroid to standard treatment will lower mortality in tetanus, although meticulous nursing care is still the most important factor in treatment.en_US
dc.identifier.citationPaydaş, S., Akoğlu, T.F., Akkız, H., Özer, F. L. ve Burgut, H. R. (1988). Mortality-lowering effect of systemic corticosteroid therapy in severe tetanus. Clinical Therapeutics. 10(3), s. 276-280.en_US
dc.identifier.endpage280en_US
dc.identifier.issue3en_US
dc.identifier.startpage276en_US
dc.identifier.urihttps://pubmed.ncbi.nlm.nih.gov/3078907/
dc.identifier.urihttps://hdl.handle.net/20.500.12415/3626
dc.identifier.volume10en_US
dc.institutionauthorBurgut, Hüseyin Refik
dc.language.isoenen_US
dc.publisherNational Center for Biotechnology Informationen_US
dc.relation.ispartofClinical Therapeuticsen_US
dc.relation.publicationcategoryUlusal Hakemli Dergide Makale - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmzKY00541
dc.titleMortality-lowering effect of systemic corticosteroid therapy in severe tetanusen_US
dc.typeArticle
dspace.entity.typePublication

Dosyalar

Koleksiyon

Tıp Fakültesi Koleksiyonu